Prostatic Neoplasms: all 6,484 studies

Page 17 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.

• An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate CancerTerminatedNCT03690141Phase 2Results posted
• Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)CompletedNCT03689699Phase 1/2Results posted
• Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate CancerTerminatedNCT03689582Phase 2Results posted
• PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminatedNCT03685591Phase 1Results posted
• PSMA Imaging of Localized Prostate CancerCompletedNCT03675451Phase 2Results posted
• Home-based Exercise Intervention for Patients With Metastatic Prostate CancerCompletedNCT03672396Not applicableResults posted
• MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate CancerCompletedNCT03664193Not applicableResults posted
• PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)Active, not recruitingNCT03663218Not applicableResults posted
• Prostate Cancer - Patient Empowerment ProgramCompletedNCT03660085Not applicableResults posted
• CivaSheet With Radical Prostatectomy & Adjuvant External Beam RadiationTerminatedNCT03657108Not applicableResults posted
• Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate CancerTerminatedNCT03649841Phase 2Results posted
• Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerCompletedNCT03646162Phase 2Results posted
• Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.CompletedNCT03644303Not applicableResults posted
• Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate CancerActive, not recruitingNCT03637543Phase 2Results posted
• MRI Guided Prostate Cancer Focal Laser AblationTerminatedNCT03634579Not applicableResults posted
• A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy ApproachesTerminatedNCT03632655Not applicableResults posted
• EXERCISING TOGETHER for Couples Coping With CancerCompletedNCT03630354Not applicableResults posted
• 68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate CancerCompletedNCT03617588Phase 2Results posted
• pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate CancerActive, not recruitingNCT03600350Phase 2Results posted
• Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer BiopsyCompletedNCT03585660Not applicableResults posted
• Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or ProstateActive, not recruitingNCT03582475Phase 1Results posted
• De-implementation of Low Value Castration for Men With Prostate CancerCompletedNCT03579680Not applicableResults posted
• Study of HPN424 in Patients With Advanced Prostate CancerTerminatedNCT03577028Phase 1/2Results posted
• Rucaparib and Nivolumab in Patients With Prostate or Endometrial CancerTerminatedNCT03572478Phase 1/2Results posted
• A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local TreatmentCompletedNCT03572387Phase 2Results posted
• Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical ProstatectomyCompletedNCT03570827Phase 2Results posted
• Olaparib Before Surgery in Treating Participants With Localized Prostate CancerTerminatedNCT03570476Phase 2Results posted
• Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate CancerCompletedNCT03565835Phase 2Results posted
• FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)CompletedNCT03556904Phase 2Results posted
• COMbination of Bipolar Androgen Therapy and NivolumabCompletedNCT03554317Phase 2Results posted
• HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate CancerTerminatedNCT03553602Phase 1/2Results posted
• 177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPCTerminatedNCT03545165Phase 1/2Results posted
• Rucaparib in Nonmetastatic prOstAte With BRCAnessTerminatedNCT03533946Phase 2Results posted
• Nutrition and Prostate CancerTerminatedNCT03532308Phase 3Results posted
• Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide TreatmentTerminatedNCT03531827Phase 2Results posted
• M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT03517969Phase 2Results posted
• Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerCompletedNCT03511664Phase 3Results posted
• Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen SuppressionCompletedNCT03507608Early Phase 1Results posted
• Fluciclovine-PET/CT for Bone Metastases From Prostate AdenocarcinomaCompletedNCT03496844Not applicableResults posted
• Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation TherapyCompletedNCT03496805Phase 2Results posted
• Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)CompletedNCT03493945Phase 1/2Results posted
• 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)CompletedNCT03490032Phase 1/2Results posted
• Efficacy of a Couple-Focused mHealth Symptom Self-management ProgramCompletedNCT03489057Not applicableResults posted
• Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy VaccinesCompletedNCT03481816Phase 1Results posted
• Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate CancerTerminatedNCT03478904Phase 1Results posted
• RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body RadiotherapyTerminatedNCT03458234Not applicableResults posted
• ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate CancerCompletedNCT03456804Phase 2Results posted
• Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03448458Phase 2Results posted
• A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer ImagingActive, not recruitingNCT03445559Not applicableResults posted
• Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate CancerTerminatedNCT03439033Phase 2Results posted
• Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT03437941Phase 1/2Results posted
• The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy FemalesTerminatedNCT03436745Phase 1Results posted
• BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair GenesTerminatedNCT03432897Phase 2Results posted
• PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate CancerCompletedNCT03429244Phase 2Results posted
• Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelActive, not recruitingNCT03419234Phase 2Results posted
• Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on TherapyCompletedNCT03418324Phase 2Results posted
• Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT03414034Phase 2Results posted
• Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene MutationsCompletedNCT03413995Phase 2Results posted
• Apalutamide in Treating Patients With Prostate Cancer Before Radical ProstatectomyActive, not recruitingNCT03412396Phase 2Results posted
• Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03406858Phase 2Results posted
• BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007CompletedNCT03400150Not applicableResults posted
• Gallium-68 PSMA-11 PET in Patients With Biochemical RecurrenceCompletedNCT03396874Phase 2Results posted
• 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate CancerCompletedNCT03389451Phase 2/3Results posted
• Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy RadiotherapyCompletedNCT03388619Phase 1Results posted
• 68Ga PSMA in Preprostatectomy PatientsCompletedNCT03388346Phase 2/3Results posted
• A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate CancerCompletedNCT03373006Phase 2Results posted
• Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE TrialActive, not recruitingNCT03371719Phase 2Results posted
• Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate CancerTerminatedNCT03366792Not applicableResults posted
• Project HERO: Health Empowerment & Recovery OutcomesCompletedNCT03345563Not applicableResults posted
• Health Gatherings - For Your Health After CancerCompletedNCT03344757Not applicableResults posted
• Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer SurvivorsCompletedNCT03343093Not applicableResults posted
• An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate CancerCompletedNCT03338790Phase 2Results posted
• Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.Active, not recruitingNCT03317990Not applicableResults posted
• Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone MetastasisActive, not recruitingNCT03317392Phase 1/2Results posted
• Combination Immunotherapy in Biochemically Recurrent Prostate CancerCompletedNCT03315871Phase 2Results posted
• A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)CompletedNCT03311555Phase 2Results posted
• Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to BoneCompletedNCT03304418Phase 2Results posted
• ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate CancerTerminatedNCT03300505Phase 1Results posted
• High Resolution MRI Study for Prostate CancerCompletedNCT03292874Not applicableResults posted
• Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate CancerCompletedNCT03279250Phase 2Results posted
• Phase I Trial of 225Ac-J591 in Patients With mCRPCCompletedNCT03276572Phase 1Results posted
• Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRICompletedNCT03264456Phase 1/2Results posted
• High Resolution PET-MRI Before Prostate Cancer HIFUCompletedNCT03263780Phase 2Results posted
• Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate CancerCompletedNCT03261999Phase 3Results posted
• Oral Calcitriol With Ketoconazole in CRPCTerminatedNCT03261336Phase 2Results posted
• Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical ProstatectomyCompletedNCT03261271Not applicableResults posted
• Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.Active, not recruitingNCT03254420Not applicableResults posted
• Prostate SBRT for Locally Recurrent Prostate Cancer After Prior RadiotherapyCompletedNCT03253744Phase 1Results posted
• Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair DefectsCompletedNCT03248570Phase 2Results posted
• A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate CancerActive, not recruitingNCT03246347Phase 2Results posted
• PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT03218826Phase 1Results posted
• Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesActive, not recruitingNCT03217747Phase 1/2Results posted
• Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"CompletedNCT03209492Results posted
• Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT03204812Phase 2Results posted
• RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid TumoursCompletedNCT03199872Phase 1/2Results posted
• Decision Aids to Improve Knowledge in Patients With Prostate CancerCompletedNCT03182998Not applicableResults posted
• Multi-parametric Magnetic Resonance Imaging for Prostate Cancer PatientsTerminatedNCT03180398Not applicableResults posted
• PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate CancerCompletedNCT03179410Phase 2Results posted
• Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryTerminatedNCT03152786Phase 2Results posted
• Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate CancerTerminatedNCT03150056Phase 1Results posted

← Prostatic Neoplasms overview